What is he best known for?
The fields of study Dino Amadori is best known for:
- Cancer
- Chemotherapy
- Breast cancer
His Internal medicine study frequently links to related topics such as Odds ratio.
Odds ratio and Internal medicine are commonly linked in his work.
He integrates Cancer with Hormone in his research.
He combines Hormone and Cancer in his studies.
He conducts interdisciplinary study in the fields of Oncology and Gastroenterology through his research.
With his scientific publications, his incorporates both Gastroenterology and Oncology.
In his study, he carries out multidisciplinary Chemotherapy and Dexamethasone research.
In his works, Dino Amadori undertakes multidisciplinary study on Dexamethasone and Chemotherapy.
Much of his study explores Surgery relationship to Regimen.
His most cited work include:
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (6352 citations)
- Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. (259 citations)
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group. (149 citations)
What are the main themes of his work throughout his whole career to date
Fluorouracil, Cyclophosphamide and Cisplatin are the subject areas of his Chemotherapy study.
He incorporates Cisplatin and Chemotherapy in his research.
Borrowing concepts from Gastroenterology, Dino Amadori weaves in ideas under Internal medicine.
Dino Amadori incorporates Gastroenterology and Oncology in his studies.
He merges Oncology with Pathology in his study.
He integrates Pathology and Internal medicine in his research.
His multidisciplinary approach integrates Cancer and Gene in his work.
In his articles, he combines various disciplines, including Gene and Cancer.
He integrates several fields in his works, including Breast cancer and Metastatic breast cancer.
Dino Amadori most often published in these fields:
- Internal medicine (85.88%)
- Cancer (70.59%)
- Oncology (51.76%)
What were the highlights of his more recent work (between 2014-2019)?
- Internal medicine (100.00%)
- Cancer (83.33%)
- Oncology (66.67%)
In recent works Dino Amadori was focusing on the following fields of study:
Dino Amadori merges Internal medicine with Family medicine in his study.
Dino Amadori integrates many fields, such as Family medicine and Internal medicine, in his works.
His multidisciplinary approach integrates Cancer and Neutropenia in his work.
He performs integrative Neutropenia and Chemotherapy research in his work.
Dino Amadori performs integrative study on Chemotherapy and Cyclophosphamide.
He merges many fields, such as Cyclophosphamide and Cancer, in his writings.
He combines Oncology and Gastroenterology in his studies.
Dino Amadori merges Gastroenterology with Oncology in his study.
Many of his studies on Pathology apply to Pathological as well.
Between 2014 and 2019, his most popular works were:
- Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial (118 citations)
- Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone (106 citations)
- Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial (64 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
